Health Care

The private equity titan will likely gain preferential negotiating rights in talks to buy a majority stake in Panasonic’s healthcare unit, a deal potentially worth $1.5 billion.

With concerns over healthcare costs and access top of mind for most, consumers should be aware of changes to the Affordable Care Act going into effect this year. The deadline for open enrollment is Jan. 31.

If you've paid into Social Security, you may qualify for Medicare even after living abroad.

As many of 35,000 Californians who think they have signed up for health insurance through the state’s exchange might be in for a rude awakening in January.

Merck will buy Cubist Pharmaceuticals in a $9.5 billion deal, giving the major drugmaker an entry into the market for drugs that target so-called superbugs.

Johnson & Johnson CEO Alex Gorsky joined FBN’s Maria Bartiromo to discuss the company’s second-quarter earnings.

U.S. health-care companies are stepping up efforts to merge with rivals from overseas, seeking to benefit from lower tax rates in countries like the UK.

Walgreen's same-store sales climbed 7.5% in June, citing strength in the pharmacy segment.

More Americans are smoking and eating marijuana as negative perceptions about the plant continue to fade, according to a United Nations report. 

Walgreen's third-quarter earnings rose 15.7% amid stronger sales of prescription drugs.

Allergan once again rejected Valeant's efforts to acquire the Botox maker, telling its shareholders to turn down an unsolicited tender offer.

Medtronic announced a $42.9 billion deal to acquire rival medical device maker Covidien, creating a formidable competitor to Johnson & Johnson's device business.

Botox maker Allergan said its board rejected the latest buyout offer from Valeant Pharmaceuticals and Bill Ackman's Pershing Square.

The Center for Disease Control and Prevention reports someone loses a limb from diabetic complications every 20 seconds. But doctors at the University of Arizona Medical Center, in Tucson, Arizona, have found a way to prevent the development of these ulcers, and it's as simple as putting on a pair of socks

Three major drug companies announced positive results for melanoma on Monday, offering advances in the treatment of the deadliest type of skin cancer. 

Activist investor Bill Ackman is calling for a special meeting of Allergan shareholders in hopes of ousting six board members, according to a regulatory filing on Monday.

Valeant Pharmaceuticals said it would hike its cash-and-stock offer to buy Botox-maker Allergan -- a move that's backed by Pershing Square's Bill Ackman.

Valeant sweetened its takeover bid for Botox maker Allergan, offering to buy the company for $49.4 billion.

AstraZeneca shares slumped Tuesday after Pfizer said it would not make a formal bid to acquire its smaller British rival.

AstraZeneca rejected Pfizer’s final takeover offer on Monday, saying it still undervalues the drug giant.